Validation and Application of an Innovative Protective Group Concept: Enhancing Substrate Reactivity in Glycosylations by Disrupting Intermolecular Interactions

Kumpei Yano; Takuya Yoshimoto; Masato Tsutsui; Yoshiyuki Manabe; Koichi Fukase

doi:10.1055/a-2269-7680

Synlett, Inhaltsverzeichnis

Synlett 2024; 35(11): 1253-1258
DOI: 10.1055/a-2269-7680

cluster

Japan/Netherlands Gratama Workshop

Validation and Application of an Innovative Protective Group Concept: Enhancing Substrate Reactivity in Glycosylations by Disrupting Intermolecular Interactions

Kumpei Yano‡

^aDepartment of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka 560-0043, Japan

,

Takuya Yoshimoto‡

^aDepartment of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka 560-0043, Japan

,

Masato Tsutsui

^aDepartment of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka 560-0043, Japan

,

Yoshiyuki Manabe∗

^aDepartment of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka 560-0043, Japan

^bForefront Research Center, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka 560-0043, Japan

,

Koichi Fukase∗

^aDepartment of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka 560-0043, Japan

^bForefront Research Center, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka 560-0043, Japan

^cCenter for Advanced Modalities and DDS, Osaka University, 1-1 Yamadaoka, Suita, Osaka 565-0871, Japan

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

We have established an innovative protective approach that disrupts intermolecular interactions to enhance substrate reactivity. Specifically, diacetylimide protection of acetamide prevents the formation of hydrogen bonds, while the incorporation of tert-butyl groups on the aromatic protecting group disrupts π-stacking interactions, both of which culminate in heightened reactivity in glycosylations. We explored the synergistic implementation of these protective measures and applied them to the synthesis of 6-sulfo sialyl Lewis X.

Key words

protecting groups - intermolecular interactions - glycan synthesis - 6-sulfo sialyl Lewis X - sialic acid

Volltext

Referenzen

References and Notes
1 Bertozzi CR, Kiessling LL. Science 2001; 291: 2357
2 Varki A. Trends Mol. Med. 2008; 14: 351

3a Skehel JJ, Wiley DC. Annu. Rev. Biochem. 2000; 69: 531
3b Stencel-Baerenwald JE, Reiss K, Reiter DM, Stehle T, Dermody TS. Nat. Rev. Microbiol. 2014; 12: 739

4a Crocker PR, Paulson JC, Varki A. Nat. Rev. Immunol. 2007; 7: 255
4b Macauley MS, Crocker PR, Paulson JC. Nat. Rev. Immunol. 2014; 14: 653

5a Hemmerich S, Leffler H, Rosen SD. J. Biol. Chem. 1995; 270: 12035
5b Mitsuoka C, Sawada-Kasugai M, Ando-Furui K, Izawa M, Nakanishi H, Nakamura S, Ishida H, Kiso M, Kannagi R. J. Biol. Chem. 1998; 273: 11225
5c Tvaroška I, Selvaraj C, Koča J. Molecules 2020; 25: 2835

6a Nicolaou KC, Mitchell HJ. Angew. Chem. Int. Ed. 2001; 40: 1576
6b Shivatare SS, Wong C.-H. J. Org. Chem. 2020; 85: 15780

7a Guo J, Ye XS. Molecules 2010; 15: 7235
7b Tokatly AI, Vinnitskiy DZ, Ustuzhanina NE, Nifantiev NE. Russ. J. Bioorg. Chem. 2021; 47: 53

8 Chatterjee S, Moon S, Hentschel F, Gilmore K, Seeberger PH. J. Am. Chem. Soc. 2018; 140: 11942
9 Kononov LO, Fukase K, Bunkin NF. Front. Chem. 2023; 11: 1293697
10 Kononov LO. RSC Adv. 2015; 5: 46718
11 Rak D, Sedlák M. Langmuir 2023; 39: 1515

12a Demchenko AV, Boons G.-J. Tetrahedron Lett. 1998; 39: 3065
12b Crich D, Dudkin V. J. Am. Chem. Soc. 2001; 123: 6819
12c Kononov LO, Malysheva NN, Kononova EG, Orlova AV. Eur. J. Org. Chem. 2008; 3251
12d Kononov LO, Malysheva NN, Orlova AV, Zinin AI, Laptinskaya TV, Kononova EG, Kolotyrkina NG. Eur. J. Org. Chem. 2012; 1926
12e Kuir D, Guillemineau M, Auzanneau F.-I. J. Org. Chem. 2015; 80: 5004

13a Nagasaki M, Manabe Y, Minamoto N, Tanaka K, Silipo A, Molinaro A, Fukase K. J. Org. Chem. 2016; 81: 10600
13b Zhou J, Manabe Y, Tanaka K, Fukase K. Chem. Asian J. 2016; 11: 1436
13c Tsutsui M, Sianturi J, Masui S, Tokunaga K, Manabe Y, Fukase K. Eur. J. Org. Chem. 2020; 1802
13d Shirakawa A, Manabe Y, Marchetti R, Yano K, Masui S, Silipo A, Molinaro A, Fukase K. Angew. Chem. Int. Ed. 2021; 60: 24686
13e Fukase K, Manabe Y, Shimoyama A. Front. Chem. 2023; 11: 1319883

14 Asano S, Tanaka H.-N, Imamura A, Ishida H, Ando H. Org. Lett. 2019; 21: 4197

15a Pudelko M, Bull J, Kunz H. ChemBioChem 2010; 11: 904
15b Kameyama A, Ishida H, Kiso M, Hasegawa A. Carbohydr. Res. 1991; 209: C1
15c Nicolaou KC, Hummel CW, Iwabüchi Y. J. Am. Chem. Soc. 1992; 114: 3126
15d Danishefsky SJ, Gervay J, Peterson JM, McDonald FE, Koseki K, Griffith DA, Oriyama T, Marsden SP. J. Am. Chem. Soc. 1995; 117: 1940
15e Kiyoi T, Nakai Y, Kondo H, Ishida H, Kiso M, Hasegawa A. Bioorg. Med. Chem. 1996; 4: 1167
15f Ellervik U, Magnusson G. J. Org. Chem. 1998; 63: 9314
15g Gege C, Vogel J, Bendas G, Rothe U, Schmidt RR. Chem. Eur. J. 2000; 6: 111
15h Hanashima S, Castagner B, Esposito D, Nokami T, Seeberger PH. Org. Lett. 2007; 9: 1777
15i Vohra Y, Buskas T, Boons G.-J. J. Org. Chem. 2009; 74: 6064
15j Soriano del Amo D, Wang W, Besanceney C, Zheng T, He Y, Gerwe B, Seidel RD, Wu P. Carbohydr. Res. 2010; 345: 1107
15k Lu D, Hu Y, He X, Sollogoub M, Zhang Y. Carbohydr. Res. 2014; 383: 89
15l Akçay G, Ramphal JY, d’Alarcao M, Kumar K. Tetrahedron Lett. 2015; 56: 109
15m Krishnamurthy VR, Sardar MY. R, Ying Y, Song X, Haller C, Dai E, Wang X, Hanjaya-Putra D, Sun L, Morikis V, Simon SI, Woods RJ, Cummings RD, Chaikof EL. Nat. Commun. 2015; 6: 6387
15n Sardar MY. R, Mandhapati AR, Park S, Wever WJ, Cummings RD, Chaikof EL. J. Org. Chem. 2018; 83: 4963

16a Komba S, Galustian C, Ishida H, Feizi T, Kannagi R, Kiso M. Angew. Chem. Int. Ed. 1999; 38: 1131
16b Misra AK, Ding Y, Lowe JB, Hindsgaul O. Bioorg. Med. Chem. Lett. 2000; 10: 1505
16c Pratt MR, Bertozzi CR. Org. Lett. 2004; 6: 2345
16d Yamaguchi M, Ishida H, Kanamori A, Kannagi R, Kiso M. Glycoconjugate J. 2005; 22: 95
16e Pazynina G, Sablina M, Mayzel M, Nasonov V, Tuzikov A, Bovin N. Glycobiology 2009; 19: 1078
16f Santra A, Yu H, Tasnima N, Muthana MM, Li Y, Zeng J, Kenyon NJ, Louie AY, Chen X. Chem. Sci. 2016; 7: 2827
16g Yuge S, Tateishi A, Numata K, Ohmae M. Biomacromolecules 2022; 23: 316

17 Synthesis of 16: To a mixture of freeze-dried donor 11 (38.9 mg, 0.0315 mmol), acceptor 12 (30.0 mg, 0.0315 mmol), and freshly activated powder MS 4Å (70.0 mg) was added anhydrous Et₂O (0.32 mL) at r.t. To the donor and acceptor solution was then added TMSOTf (5.7 μL, 32.0 μmol) at –40 °C. After stirring for 1 h at –40 °C, the reaction was quenched with saturated aqueous NaHCO₃. The aqueous layer was extracted with CH₂Cl₂ and the organic layer was dried over Na₂SO₄, filtered, and concentrated in vacuo. The residue was purified by silica-gel column chromatography (toluene/EtOAc, 3:1 to EtOAc) to give 16 (54.4 mg, 86%) as a white powder. The stereoselectivity of the glycosylation was verified by the large coupling constant observed between Gal-H1 and Gal-H2 (J = 8.2 Hz). ¹H NMR (500 MHz, CDCl₃): δ = 8.22 (d, J = 7.5 Hz, 2 H, aromatic), 8.02 (d, J = 8.3 Hz, 2 H, aromatic), 7.99 (d, J = 7.5 Hz, 2 H, aromatic), 7.82 (s, 1 H, aromatic), 7.79–7.73 (m, 3 H, aromatic), 7.56 (t, J = 7.5 Hz, 1 H, aromatic), 7.51–7.46 (m, 6 H, aromatic), 7.38–7.29 (m, 7 H, aromatic), 7.22–7.18 (m, 12 H, aromatic), 6.10 (d, J = 8.0 Hz, 1 H, -NH-Troc), 5.67–5.60 (m, 2 H, Sia-H8, -CH₂CH=CH₂), 5.49–5.36 (m, 4 H, Sia-H4, Fuc-H1, Gal-H2, Gal-H4), 5.11 (d, J = 8.2 Hz, 1 H, Gal-H1), 5.07 (d, J = 17.2 Hz, 1 H, -CH₂CH=CH₂), 5.02–4.99 (m, 2 H, Sia-H7, -CH₂CH=CH₂), 4.93–4.86 (m, 4 H, GlcN-H1, Gal-H3), 4.76–4.70 (m, 5 H), 4.58 (dd, J = 10.2, 2.4 Hz, 1 H, Sia-H6), 4.54 (d, J = 11.6 Hz, 1 H), 4.47 (q, J = 6.4 Hz, 1 H, Fuc-H5), 4.32–4.24 (m, 4 H, Gal-H6a, Gal-H6b), 4.19 (dd, J = 12.5, 2.3 Hz, 1 H, Sia-H9a), 4.12 (t, J = 9.2 Hz, 1 H, GlcN-H4), 4.07–4.03 (m, 4 H, GlcN-H3, Fuc-H2, Fuc-H3, Gal-H5), 4.00–3.90 (m, 4 H, Sia-H5, Sia-H9b, GlcN-H6b, CH₂CH=CH₂), 3.89–3.76 (m, 6 H, GlcN-H2, GlcN-H6a, CH₂CH=CH₂, OCOCH₃), 3.59–3.57 (m, 2 H, GlcN-H5, Fuc-H4), 2.49 (dd, J = 12.4, 5.0 Hz, 1 H, Sia-H3_eq), 2.29 (s, 3 H, Ac), 2.14 (s, 3 H, Ac), 2.13 (s, 3 H, Ac), 1.96 (s, 3 H, Ac), 1.86 (s, 3 H, Ac), 1.59 (t, J = 12.4 Hz, 1 H, Sia-H3_aq), 1.44 (s, 3 H, Ac), 1.31 (d, J = 6.4 Hz, 3 H, -CH₃), 1.22 (s, 9 H, t-BuBz). ¹³C{¹H} NMR (125 MHz, CDCl₃): δ = 174.1, 173.6, 170.7, 170.5, 170.0, 169.8, 168.0, 166.2, 165.6, 164.9, 157.0, 154.2, 139.0, 138.2, 135.9, 133.6, 133.2, 133.04, 132.98, 132.85, 130.5, 130.0, 129.9, 129.8, 128.5, 128.3, 128.2, 128.12, 128.06, 127.9, 127.8, 127.6, 127.4, 127.2, 127.1, 127.0, 126.9, 126.0, 125.8, 125.6, 125.54, 125.51, 117.8, 100.1, 97.8, 96.9, 95.6, 95.5, 79.1, 78.8, 77.6, 74.9, 74.4, 73.5, 73.4, 72.9, 72.7, 72.1, 72.0, 71.4, 70.7, 69.2, 68.7, 68.5, 68.4, 67.2, 66.9, 66.8, 66.5, 62.1, 61.7, 56.1, 55.9, 53.1, 38.4, 35.0, 31.0, 28.0, 26.4, 21.4, 20.71, 20.66, 20.5, 17.0. HRMS (ESI-Orbitrap): m/z [M + Na]⁺ calcd for C₁₀₃H₁₁₃O₃₂Cl₃N₂Na: 2017.6234; found: 2017.6243.
18 Synthesis of 17: To a solution of 16 (50.0 mg, 25.0 μmol) in anhydrous THF (0.80 mL) was added [Ir(cod)(PPh₂Me)₂]PF₆ (1.1 mg, 1.3 μmol) in anhydrous THF (0.45 mL) at r.t., which was activated by H₂. After the reaction mixture was stirred for 18 h at r.t., to the reaction mixture were added H₂O (0.63 mL) and I₂ (10.1 mg, 40.0 μmol) at r.t. After stirring for 50 min at r.t., the reaction was quenched with saturated aqueous Na₂S₂O₃. The aqueous layer was extracted with EtOAc and the organic layer was dried over Na₂SO₄, filtered, and concentrated in vacuo. The residue was roughly purified by silica-gel column chromatography (toluene/EtOAc = 1:0 to 3:2) to give hemiacetal (45.6 mg, 93%) as a white powder. This α/β mixture was used for the next reaction without further purification. To a solution of the obtained hemiacetal (45.6 mg, 23.3 μmol) in anhydrous acetone (1.2 mL) were added N-phenyltrifluoroacetimidoyl chloride (10.7 mg, 52.0 μmol) and K₂CO₃ (10.2 mg, 74.0 μmol) at r.t. After stirring the reaction mixture for 4 h at r.t., to the reaction mixture were added acetone (1.2 mL), N-phenyltrifluoroacetimidoyl chloride (11.2 mg, 53.9 μmol), and K₂CO₃ (10.9 mg, 78.9 μmol) at r.t. After stirring the reaction mixture for 2 h at r.t., insoluble materials were filtered, and concentrated in vacuo. The residue was purified by silica-gel column chromatography (toluene/EtOAc = 1:0 to 3:2) to give the donor (39.7 mg, 82%) as a white powder. This α/β mixture was used for the next reaction without further purification. A mixture of freeze-dried obtained donor (35.6 mg, 16.3 μmol), 2-(benzyloxycarbonylamino)-1-ethanol (12.8 mg, 65.3 μmol), and freshly activated powder MS 4Å (48 mg) was dissolved in anhydrous CH₂Cl₂ (1.6 mL). To the donor and acceptor solution were added TMSOTf (3.0 μL, 16.0 μmol) at –78 °C. After stirring for 2 h at –78 °C, the reaction was quenched with saturated aqueous NaHCO₃. The aqueous layer was extracted with CH₂Cl₂ and the organic layer was dried over Na₂SO₄, filtered, and concentrated in vacuo. The residue was purified by silica-gel column chromatography (toluene/EtOAc = 1:0 to 2:1) to give 17 (34.8 mg, quant) as a white powder. ¹H NMR (500 MHz, CDCl₃): δ = 8.21 (d, J = 7.2 Hz, 2 H, aromatic), 8.02 (d, J = 8.6 Hz, 2 H, aromatic), 7.95 (d, J = 7.3 Hz, 2 H, aromatic), 7.76–7.70 (m, 4 H, aromatic), 7.55–7.37 (m, 10 H, aromatic), 7.31–7.25 (m, 12 H, aromatic), 7.24–7.17 (m, 9 H, aromatic), 5.79 (d, J = 7.0 Hz, 1 H), 5.66–5.62 (m, 1 H, Sia-H8), 5.50–5.40 (m, 4 H, Sia-H4), 5.12 (s, 1 H), 5.05–5.01 (m, 4 H, Sia-H7), 4.97 (dd, J = 10.1, 3.7 Hz, 1 H), 4.75–4.71 (m, 4 H), 4.65–4.63 (m, 2 H), 4.61 (dd, J = 10.2, 2.5 Hz, 1 H, Sia-H6), 4.55–4.53 (m, 2 H), 4.46 (d, J = 11.8 Hz, 1 H), 4.33–4.24 (m, 5 H, Fuc-H4, Sia-H9a), 4.13–4.10 (m, 2 H, Fuc-H5), 4.06–3.93 (m, 5 H, Sia-H5, Sia-H9b), 3.87 (s, 3 H, OCOCH₃), 3.82–3.75 (m, 3 H), 3.59–3.54 (m, 2 H), 3.43 (d, J = 5.7 Hz, 1 H), 3.31 (d, J = 1.9 Hz, 1 H), 3.23–3.21 (m, 3 H), 2.51 (dd, J = 12.4, 5.4 Hz, 1 H, Sia-H3_eq), 2.29 (s, 3 H, Ac), 2.16 (s, 3 H, Ac), 2.15 (s, 3 H, Ac), 1.96 (s, 3 H, Ac), 1.86 (s, 3 H, Ac), 1.60 (t, J = 12.4 Hz, 1 H, Sia-H3_aq), 1.47 (s, 3 H, Ac), 1.28 (s, 9 H, t-BuBz), 1.17 (d, J = 6.4 Hz, 3 H, -CH₃). ¹³C{¹H} NMR (125 MHz, CDCl₃): δ = 174.1, 173.6, 170.7, 170.6, 170.0, 169.8, 168.0, 166.1, 165.6, 165.4, 157.1, 156.5, 154.1, 138.9, 138.8, 138.4, 136.7, 135.8, 133.3, 133.2, 133.0, 132.9, 130.2, 130.1, 129.9, 129.8, 129.7, 128.6, 128.5, 128.3, 128.24, 128.23, 128.19, 128.11, 128.04, 128.00, 127.9, 127.75, 127.70, 127.6, 127.4, 127.2, 127.1, 126.7, 126.1, 126.0, 125.8, 125.6, 125.5, 100.7, 100.0, 96.9, 95.5, 79.0, 78.3, 76.5, 75.1, 75.0, 74.4, 73.3, 73.0, 72.5, 71.52, 71.47, 69.3, 68.7, 68.4, 67.08, 66.98, 66.94, 66.6, 62.1, 62.0, 56.0, 53.1, 40.9, 38.3, 35.1, 31.1, 28.0, 26.5, 21.5, 20.68, 20.67, 20.5, 16.7. HRMS (ESI-Orbitrap): m/z [M + Na]⁺ calcd for C₁₁₀H₁₂₀O₃₄Cl₃N₃Na: 2154.6711; found: 2154.6721.
19 Synthesis of 18: To a solution of 17 (31.0 mg, 14.5 μmol) in CH₂Cl₂ (0.58 mL) and MeOH (0.15 mL) was added DDQ (16.5 mg, 73.0 μmol) at r.t. After stirring for 3 h at r.t., the reaction was quenched with saturated aqueous NaHCO₃. The aqueous layer was extracted with CH₂Cl₂ and the organic layer was dried over Na₂SO₄, filtered, and concentrated in vacuo. The residue was purified by silica-gel column chromatography (1st: toluene/EtOAc = 2:3, 2nd: toluene/EtOAc = 1:1) to give the crude product (16.3 mg) as an inseparable mixture. This crude mixture was used for the next reaction without further purification. To a solution of crude product (16.3 mg, 8.17 μmol) in anhydrous DMF (0.82 mL) was added SO₃·Py (13.0 mg, 81.7 μmol) at r.t. After stirring the reaction mixture for 10 h at r.t., SO₃·Py (65.0 mg, 0.409 mmol) was added at r.t.. After stirring for 17 h at r.t., the reaction mixture was concentrated in vacuo. The pyridinium salt was exchanged to the sodium salt by eluting over Dowex^®(Na⁺) ion-exchange resin, and the eluent was concentrated in vacuo. The crude product was purified by chromatography on silica-gel (CH₂Cl₂/MeOH/Et₃N = 100:0:0.1 to 93.8:6.3:0.1) to give 18 (16.1 mg, 53% in 2 steps) as a white powder. ¹H NMR (500 MHz, CD₃OD): δ = 8.17 (d, J = 7.6 Hz, 2 H, aromatic), 8.04–8.00 (m, 4 H, aromatic), 7.56–7.37 (m, 8 H, aromatic), 7.22–7.09 (m, 15 H, aromatic), 7.01–6.92 (m, 5 H, aromatic), 5.69 (s, 1 H, Gal-H4), 5.49 (t, J = 9.2 Hz, 1 H, Gal-H2), 5.36–5.29 (m, 2 H, Gal-H1, Sia-H4), 5.27 (d, J = 3.3 Hz, 1 H, Fuc-H1), 5.21 (s, 1 H), 5.03 (d, J = 7.9 Hz, 1 H), 4.97–4.94 (m, 3 H), 4.90 (dd, J = 10.1, 3.2 Hz, 1 H, Gal-H3), 4.66–4.61 (m, 3 H, Fuc-H5), 4.51–4.46 (m, 4 H, Gal-H6a), 4.41 (d, J = 11.9 Hz, 1 H), 4.37 (dd, J = 12.8 2.4 Hz, 1 H), 4.34–4.24 (m, 4 H, Gal-H5, GlcN-H1), 4.14 (d, J = 10.6 Hz, 1 H), 4.05–4.02 (m, 4 H, Fuc-H3, Gal-H6b), 3.87–3.83 (m,3 H, GlcN-H3, Sia-H5), 3.78 (dd, J = 10.2, 3.7 Hz, 1 H, Fuc-H2), 3.65 (s, 1 H), 3.57 (s, 1 H, Fuc-H4), 3.52–3.49 (m, 1 H, GlcN-H2), 3.41–3.37 (m, 1 H), 3.21 (m, 6 H), 3.15–3,12 (m, 2 H), 3.07 (q, J = 7.3 Hz, 2 H), 2.27 (s, 3 H, Ac), 2.18 (s, 3 H, Ac), 2.11–2.06 (m, 5 H, Ac, Sia-H3_eq,Sia-H3_aq), 1.90 (m, 6 H, Ac), 1.85 (s, 3 H, Ac), 1.38 (d, J = 6.4 Hz, 3 H), 1.19–1.16 (m, 4 H), 1.13 (s, 9 H, t-BuBz). ¹³C{¹H} NMR (125 MHz, CD₃OD): δ = 176.7, 176.6, 172.4, 172.1, 171.4, 169.0, 167.6, 167.5, 167.3, 166.5, 158.6, 156.7, 140.3, 140.0, 139.9, 138.3, 138.2, 134.7, 134.3, 131.3, 131.2, 131.0, 130.7, 130.0, 129.9, 129.5, 129.2, 129.14, 129.1, 129.04, 128.99, 128.85, 128.75, 128.6, 128.3, 128.1, 127.9, 126.8, 103.1, 101.7, 101.3, 100.9, 98.2, 96.9, 81.3, 79.6, 77.5, 76.9, 76.2, 75.6, 74.9, 74.7, 73.5, 73.3, 73.2, 73.1, 71.9, 71.3, 71.1, 69.6, 68.1, 67.9, 67.7, 67.5, 63.4, 62.8, 59.7, 59.3, 53.2, 48.0, 41.9, 36.0, 31.5, 27.9, 25.9, 21.3, 20.9, 20.72, 20.68, 17.5, 9.3. HRMS (ESI-Orbitrap): m/z [M + Na]⁺ calcd for C₉₉H₁₁₁O₃₇Cl₃N₃SNa: 2116.5473; found: 2116.5461.
20 Synthesis of 19: To a solution of 18 (20.0 mg 9.54 μL) in THF (2.4 mL) was added 1 M aqueous NaOH (191.0 μL) at r.t. After stirring for 12 h at r.t., 1 M aqueous NaHCO₃ (47.7 μL), H₂O (450.0 μL), and Ac₂O (4.50 μL, 47.7 μmol) were added at r.t. After stirring for 24 h at r.t., 1 M aqueous NaHCO₃ (47.7 μL), H₂O (450.0 μL), and Ac₂O (4.50 μL, 47.7 μmol) were added at r.t. After stirring for 29 h at r.t., 1 M aqueous NaHCO₃ (47.7 μL), and Ac₂O (4.50 μL, 47.7 μmol) were added at r.t. After stirring for 24 h at r.t., the reaction mixture was quenched with 1 M aqueous HCl and freeze-dried with H₂O. This crude mixture was used for the next reaction without further purification. To a solution of the obtained mixture in _t BuOH/H₂O/AcOH = 10:8:1 (950.0 μL) was added a solution of 50% Pd(OH)₂ (13.4 mg, 47.7 μmol) in H₂O (150.0 μL) at r.t. After stirring for 4 h under H₂ atmosphere (balloon) at r.t., the catalyst was removed by centrifugation. The supernatant layer was freeze-dried with H₂O. This crude mixture was used for the next reaction without further purification. To a solution of obtained mixture in H₂O (382.0 μL), and acetone (572.0 μL) were added 1 M aqueous NaHCO₃ (38.2 μL) and FmocOSu (19.3 mg, 57.2 μmol) at r.t. After stirring for 1 h at r.t., 1 M aqueous NaHCO₃ (38.2 μL) and FmocOSu (19.3 mg, 57.2 μmol) were added at r.t. After stirring for 41 h at r.t., the reaction mixture was concentrated in vacuo and freeze-dried with H₂O and purified by reverse-phase HPLC (Nacalai, COSMOSIL 5C₁₈-AR-300, 10ID × 250 mm column, 15→35% MeCN aq. containing 10 mM ammonium formate for 40 min, flow rate 4.0 mL min^–1) to give 19 as a white powder (6.3 mg, 56% in 3 steps). ¹H NMR (500 MHz, D₂O): δ = 7.81 (d, J = 7.6 Hz, 2 H, aromatic), 7.60(d, J = 7.2 Hz, 2 H, aromatic), 7.39 (t, J = 7.6 Hz, 2 H, aromatic), 7.32 (t, J = 7.2 Hz, 2 H, aromatic), 4.94 (d, J = 3.0 Hz, 1 H, anomeric), 4.69–4.52 (m, 3 H, NHCOOCH₂), 4.50–4.47 (m, 2 H, anomeric), 4.33–4.15 (m, 3 H, anomeric), 3.98 (d, J = 8.6 Hz, 1 H), 3.83–3.39 (m, 21 H), 3.06 (s, 2 H, OCH₂CH₂NH), 2.63 (dd, J = 12.5, 4.6 Hz, 1 H, Sia-H3_eq), 1.91 (s, 3 H, Ac), 1.71 (s, 3 H, Ac), 1.69 (d, J = 12.5 Hz, 1 H, Sia-H3_aq), 1.06 (d, J = 5.7 Hz, 1 H, -CH₃). ¹³C{¹H} NMR (226 MHz, D₂O): δ = 174.9, 174.0, 171.0, 158.2, 143.9, 143.8, 140.96, 140.93, 128.0, 127.50, 127.46, 125.0, 124.9, 124.6, 120.1, 101.1, 100.9, 99.5, 98.5, 75.4, 74.8, 74.5, 72.8, 72.6, 71.8, 71.3, 69.4, 69.1, 68.7, 68.4, 68.0, 67.7, 67.2, 66.7, 65.9, 65.8, 62.5, 61.4, 55.5, 51.7, 47.0, 40.2, 39.6, 22.02, 22.00, 15.3. HRMS (ESI-Orbitrap): m/z [M – Na – H]^2– calcd for C₄₈H₆₅O₂₈N₃S: 581.6743; found: 581.6750.

Zusatzmaterial

Supporting Information